Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Arcadia Biosciences (RKDA) has provided an announcement.
Arcadia Biosciences announced key executive changes, with Stanley Jacot resigning as president, CEO, and director, and the company agreeing to a hefty severance package including cash, stock option vesting, and health insurance coverage. Thomas J. Schaefer steps up as the new CEO, bringing a wealth of finance experience and a solid educational background. Mark Kawakami fills Schaefer’s former CFO role, equipped with a strong analytical background and diverse financial expertise.
Find detailed analytics on RKDA stock on TipRanks’ Stock Analysis page.